Packaged Foods
Compare Stocks
4 / 10Stock Comparison
ATPC vs NATR vs USNA vs NHTC
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Packaged Foods
Specialty Retail
ATPC vs NATR vs USNA vs NHTC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | Packaged Foods | Packaged Foods | Specialty Retail |
| Market Cap | $136M | $430M | $359M | $36M |
| Revenue (TTM) | $1M | $490M | $925M | $38M |
| Net Income (TTM) | $-3M | $20M | $11M | $-1M |
| Gross Margin | 52.7% | 69.9% | 76.6% | 73.8% |
| Operating Margin | -189.0% | 5.7% | 5.5% | -5.1% |
| Forward P/E | — | 21.9x | 11.2x | — |
| Total Debt | $363K | $19M | $14M | $3M |
| Cash & Equiv. | $2M | $94M | $158M | $7M |
ATPC vs NATR vs USNA vs NHTC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Agape ATP Corporati… (ATPC) | 100 | 0.0 | -100.0% |
| Nature's Sunshine P… (NATR) | 100 | 167.7 | +67.7% |
| USANA Health Scienc… (USNA) | 100 | 21.1 | -78.9% |
| Natural Health Tren… (NHTC) | 100 | 44.6 | -55.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ATPC vs NATR vs USNA vs NHTC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ATPC lags the leaders in this set but could rank higher in a more targeted comparison.
NATR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.62
- Rev growth 5.7%, EPS growth 165.0%, 3Y rev CAGR 4.4%
- 180.2% 10Y total return vs NHTC's -63.6%
- 4.1% margin vs ATPC's -183.0%
USNA is the #2 pick in this set and the best alternative if growth and value is your priority.
- 8.3% revenue growth vs ATPC's -7.6%
- Better valuation composite
NHTC is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.58, Low D/E 13.4%, current ratio 2.50x
- Beta 0.58, yield 25.0%, current ratio 2.50x
- Beta 0.58 vs USNA's 1.34
- 25.0% yield; the other 3 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.3% revenue growth vs ATPC's -7.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 4.1% margin vs ATPC's -183.0% | |
| Stability / Safety | Beta 0.58 vs USNA's 1.34 | |
| Dividends | 25.0% yield; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +85.3% vs ATPC's -96.8% | |
| Efficiency (ROA) | 7.6% ROA vs ATPC's -11.1%, ROIC 21.0% vs -16.2% |
ATPC vs NATR vs USNA vs NHTC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ATPC vs NATR vs USNA vs NHTC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NATR leads in 4 of 6 categories
USNA leads 1 • ATPC leads 0 • NHTC leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NATR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
USNA is the larger business by revenue, generating $925M annually — 623.1x ATPC's $1M. NATR is the more profitable business, keeping 4.1% of every revenue dollar as net income compared to ATPC's -183.0%. On growth, ATPC holds the edge at +11.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $490M | $925M | $38M |
| EBITDAEarnings before interest/tax | -$3M | $38M | $91M | -$2M |
| Net IncomeAfter-tax profit | -$3M | $20M | $11M | -$1M |
| Free Cash FlowCash after capex | -$3M | $23M | $9M | -$6M |
| Gross MarginGross profit ÷ Revenue | +52.7% | +69.9% | +76.6% | +73.8% |
| Operating MarginEBIT ÷ Revenue | -189.0% | +5.7% | +5.5% | -5.1% |
| Net MarginNet income ÷ Revenue | -183.0% | +4.1% | +1.2% | -3.0% |
| FCF MarginFCF ÷ Revenue | -192.1% | +4.7% | +0.9% | -16.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.9% | +8.5% | +5.9% | -14.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +92.3% | +16.0% | -142.2% | -2.4% |
Valuation Metrics
USNA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 23.2x trailing earnings, NATR trades at a 31% valuation discount to USNA's 33.6x P/E. On an enterprise value basis, USNA's 2.4x EV/EBITDA is more attractive than NATR's 9.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $136M | $430M | $359M | $36M |
| Enterprise ValueMkt cap + debt − cash | $134M | $355M | $215M | $32M |
| Trailing P/EPrice ÷ TTM EPS | -4.32x | 23.16x | 33.55x | -41.72x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.92x | 11.18x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 9.20x | 2.37x | — |
| Price / SalesMarket cap ÷ Revenue | 102.83x | 0.90x | 0.39x | 0.90x |
| Price / BookPrice ÷ Book value/share | 89.51x | 2.81x | 0.62x | 1.57x |
| Price / FCFMarket cap ÷ FCF | — | 14.90x | 42.13x | — |
Profitability & Efficiency
NATR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NATR delivers a 12.1% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-12 for ATPC. USNA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATPC's 0.19x. On the Piotroski fundamental quality scale (0–9), USNA scores 7/9 vs NHTC's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -11.9% | +12.1% | +1.8% | -4.9% |
| ROA (TTM)Return on assets | -11.1% | +7.6% | +1.5% | -2.9% |
| ROICReturn on invested capital | -16.2% | +21.0% | +8.6% | -6.5% |
| ROCEReturn on capital employed | -75.8% | +13.8% | +8.3% | -6.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 7 | 2 |
| Debt / EquityFinancial leverage | 0.19x | 0.12x | 0.02x | 0.13x |
| Net DebtTotal debt minus cash | -$2M | -$75M | -$144M | -$4M |
| Cash & Equiv.Liquid assets | $2M | $94M | $158M | $7M |
| Total DebtShort + long-term debt | $362,780 | $19M | $14M | $3M |
| Interest CoverageEBIT ÷ Interest expense | — | 1100.81x | 50.32x | — |
Total Returns (Dividends Reinvested)
NATR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NATR five years ago would be worth $11,883 today (with dividends reinvested), compared to $3 for ATPC. Over the past 12 months, NATR leads with a +85.3% total return vs ATPC's -96.8%. The 3-year compound annual growth rate (CAGR) favors NATR at 31.8% vs ATPC's -92.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -48.2% | +17.1% | +0.1% | +7.1% |
| 1-Year ReturnPast 12 months | -96.8% | +85.3% | -31.4% | -20.7% |
| 3-Year ReturnCumulative with dividends | -100.0% | +129.0% | -70.7% | -5.7% |
| 5-Year ReturnCumulative with dividends | -100.0% | +18.8% | -80.0% | -9.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | +180.2% | -68.7% | -63.6% |
| CAGR (3Y)Annualised 3-year return | -92.3% | +31.8% | -33.6% | -1.9% |
Risk & Volatility
Evenly matched — ATPC and NATR each lead in 1 of 2 comparable metrics.
Risk & Volatility
ATPC is the less volatile stock with a -2.01 beta — it tends to amplify market swings less than USNA's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NATR currently trades 87.2% from its 52-week high vs ATPC's 2.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -2.01x | 0.62x | 1.34x | 0.58x |
| 52-Week HighHighest price in past year | $119.00 | $28.14 | $38.32 | $6.00 |
| 52-Week LowLowest price in past year | $0.07 | $12.90 | $16.60 | $2.40 |
| % of 52W HighCurrent price vs 52-week peak | +2.3% | +87.2% | +50.8% | +53.3% |
| RSI (14)Momentum oscillator 0–100 | 52.7 | 49.6 | 59.0 | 57.9 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 103K | 118K | 25K |
Analyst Outlook
NATR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NATR as "Buy", USNA as "Hold". Consensus price targets imply 79.9% upside for USNA (target: $35) vs -20.6% for NATR (target: $20). NHTC is the only dividend payer here at 25.04% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | — |
| Price TargetConsensus 12-month target | — | $19.50 | $35.00 | — |
| # AnalystsCovering analysts | — | 4 | 8 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +25.0% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $0.80 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.8% | +7.7% | 0.0% |
NATR leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). USNA leads in 1 (Valuation Metrics). 1 tied.
ATPC vs NATR vs USNA vs NHTC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ATPC or NATR or USNA or NHTC a better buy right now?
For growth investors, USANA Health Sciences, Inc.
(USNA) is the stronger pick with 8. 3% revenue growth year-over-year, versus -7. 6% for Agape ATP Corporation (ATPC). Nature's Sunshine Products, Inc. (NATR) offers the better valuation at 23. 2x trailing P/E (21. 9x forward), making it the more compelling value choice. Analysts rate Nature's Sunshine Products, Inc. (NATR) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ATPC or NATR or USNA or NHTC?
On trailing P/E, Nature's Sunshine Products, Inc.
(NATR) is the cheapest at 23. 2x versus USANA Health Sciences, Inc. at 33. 6x. On forward P/E, USANA Health Sciences, Inc. is actually cheaper at 11. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ATPC or NATR or USNA or NHTC?
Over the past 5 years, Nature's Sunshine Products, Inc.
(NATR) delivered a total return of +18. 8%, compared to -100. 0% for Agape ATP Corporation (ATPC). Over 10 years, the gap is even starker: NATR returned +180. 2% versus ATPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ATPC or NATR or USNA or NHTC?
By beta (market sensitivity over 5 years), Agape ATP Corporation (ATPC) is the lower-risk stock at -2.
01β versus USANA Health Sciences, Inc. 's 1. 34β — meaning USNA is approximately -167% more volatile than ATPC relative to the S&P 500. On balance sheet safety, USANA Health Sciences, Inc. (USNA) carries a lower debt/equity ratio of 2% versus 19% for Agape ATP Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ATPC or NATR or USNA or NHTC?
By revenue growth (latest reported year), USANA Health Sciences, Inc.
(USNA) is pulling ahead at 8. 3% versus -7. 6% for Agape ATP Corporation (ATPC). On earnings-per-share growth, the picture is similar: Nature's Sunshine Products, Inc. grew EPS 165. 0% year-over-year, compared to -21. 7% for Agape ATP Corporation. Over a 3-year CAGR, ATPC leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ATPC or NATR or USNA or NHTC?
Nature's Sunshine Products, Inc.
(NATR) is the more profitable company, earning 4. 1% net margin versus -186. 8% for Agape ATP Corporation — meaning it keeps 4. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USNA leads at 5. 5% versus -194. 5% for ATPC. At the gross margin level — before operating expenses — USNA leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ATPC or NATR or USNA or NHTC more undervalued right now?
On forward earnings alone, USANA Health Sciences, Inc.
(USNA) trades at 11. 2x forward P/E versus 21. 9x for Nature's Sunshine Products, Inc. — 10. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USNA: 79. 9% to $35. 00.
08Which pays a better dividend — ATPC or NATR or USNA or NHTC?
In this comparison, NHTC (25.
0% yield) pays a dividend. ATPC, NATR, USNA do not pay a meaningful dividend and should not be held primarily for income.
09Is ATPC or NATR or USNA or NHTC better for a retirement portfolio?
For long-horizon retirement investors, Agape ATP Corporation (ATPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -2.
01)). Both have compounded well over 10 years (ATPC: -100. 0%, USNA: -68. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ATPC and NATR and USNA and NHTC?
These companies operate in different sectors (ATPC (Consumer Defensive) and NATR (Consumer Defensive) and USNA (Consumer Defensive) and NHTC (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ATPC is a small-cap quality compounder stock; NATR is a small-cap quality compounder stock; USNA is a small-cap quality compounder stock; NHTC is a small-cap income-oriented stock. NHTC pays a dividend while ATPC, NATR, USNA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.